Predictive Value of Immune Cells in the Risk of Gestational Diabetes Mellitus: A Pilot Study

dc.contributor.authorFagninou, Adnette
dc.contributor.authorNekoua, P Magloire
dc.contributor.authorFiogbe, Salomon Ezechiel M
dc.contributor.authorKabirou Moutaïrou, Kabirou
dc.contributor.authorYESSOUFOU, AKADIRI
dc.date.accessioned2026-06-02T16:06:57Z
dc.date.available2026-06-02T16:06:57Z
dc.date.issued2022
dc.description.abstractAims: Immunological and biochemical parameters are gaining more and more importance in the prognosis of diabetes and its complications. Here, we assessed the predictive power of immune cells correlated with biochemical parameters in gestational diabetes mellitus (GDM). Materials and Methods: Immune cells and serum biochemical parameters were determined in women with GDM and pregnant controls. Receiver operating characteristics (ROC) curve analyses were conducted to assess the optimal cutoff and value of ratios of immune cells to biochemical parameters for predicting GDM. Results: Blood glucose, total cholesterol, LDL-cholesterol and triglycerides were significantly increased whereas HDL-cholesterol decreased in women with GDM compared to pregnant controls. Glycated haemoglobin, creatinine, transaminase activities did not significantly differ between both groups. Total leukocyte, lymphocyte and platelet numbers were significantly high in women with GDM. Correlation tests showed that ratios of lymphocyte/HDL-C, monocyte/HDL-C and granulocyte/HDL-C were significantly higher in women with GDM than in pregnant controls (p = 0.001; p = 0.009 and p = 0.004 respectively). Women with a lymphocyte/HDL-C ratio greater than 3.66 had a 4-fold increased risk of developing GDM than those with lower ratios (odds ratio 4.00; 95% CI: 1.094 – 14.630; p=0.041). Conclusion: Our study showed that ratios of lymphocyte, monocyte and granulocyte to HDL-C might represent valuable biomarkers for GDM and in particular, lymphocyte/HDL-C ratio exhibited a strong predictive power for GDM risk.
dc.identifier.doi10.3389/fcdhc.2022.819164
dc.identifier.otherBECDB-14207
dc.identifier.urihttps://dspace.uac.bj/handle/123456789/12123
dc.language.isofr
dc.relation.ispartofFrontiers in Clinical Diabetes and Healthcare
dc.subjectImmune cells
dc.subjectbiochemical parameters
dc.subjectgestational diabetes mellitus
dc.subjectpredictive value
dc.subjectlymphocyte
dc.subjectHDL-cholesterol
dc.titlePredictive Value of Immune Cells in the Risk of Gestational Diabetes Mellitus: A Pilot Study
dc.typeArticle

Files

Collections